DAPK1 and Alzheimer disease: A total of 277 target genes of quercetin and 3,256 differentially expressed genes in AD were obtained in our study, and then the functional analysis suggested that six genes (MAPT, PIK3R1, CASP8, DAPK1, MAPK1, and CYCS) were involved in the progression of AD and the treatment target of AD patients.